Use a Checklist to Help Patients Safely Take DOACs

We're getting questions about how to monitor patients on direct oral anticoagulants...apixaban, dabigatran, edoxaban, and rivaroxaban.

We know these "DOACs" (Direct Oral AntiCoagulants) don't have good lab tests to assess efficacy and bleeding risk...like INR with warfarin.

But they still need clinical monitoring to ensure appropriate use.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals